Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research and development.

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but has failed at “earning public trust,” speaking one week after the federal government canceled $500 million for its development.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 million in mRNA vaccine contracts, a hit to an industry already reeling from other public funding cuts. Those impacts are being felt in Vermont, experts say.